{
  "title": "People With Certain Medical Conditions And Covid-19 Risk Factors",
  "source": "CDC",
  "chunk_id": 20,
  "content": ", a monoclonal antibody authorized to help protect against COVID-19. Pemgarda may provide another layer of protection against COVID-19 in addition to protection provided through vaccination and can be given at least 2 weeks after receiving a COVID-19 vaccine. Pemgarda is not a treatment for COVID-19. Talk to your healthcare provider to see if Pemgarda is right for you. CDC is monitoring variants and how commonly they occur to understand if they might affect how well Pemgarda works"
}